Xeris Biopharma Holdings, Inc.
XERS • NASDAQ • Stock Fundamentals
Xeris Biopharma Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Shannon, with a market cap of $1.2B.
Market Cap$1.2B
Employees377.0
CEOJohn Shannon
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
XER
Xeris Biopharma Holdings, Inc. FAQ
Common questions about Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. (XERS) has a market capitalization of $1.2B and trades on NASDAQ.
Xeris Biopharma Holdings, Inc. has approximately 377 employees.